Views and Actions C
Points of View boxwhisker plot EU ICH http wwwinfopmdagojp n n n n n n No
n n n n n n pi pii pi pii pi pii n n n PKPD No
HTBD HTBD CD LHRH RS HTBD EGFR AT DMARD HTBD HTBD TNFα α HMGCoA TNFαLTα mg mg No
HIV n n n n n n n n No
n n n n N N N N N N N N N N N N No
Points of View No
No
No
Points of View CDROM Web n n No
n n n n No
n n No No
n n n HIV No
No
Points of View FIFA No IMS LifecyclePharmaprojects IMS Lifecycle No
ICH IMS Lifecycle ATC ATC N ATC J R G A B M L C M J G N L A M L C N C R G A B M L C N B M L C C N C C IMS World Review No
IMS LifecyclePharmaprojects No No
Points of View mg No
No
No
No No
B C HBVHCV HCV HCV HCV HCV IFNB HCV C IFN HCV HCV HCV No
C HCV HBV IFN IFN C IFN C HCV IFN HCV IFN IFN IFN HCV IFN IFN C C C C HCV C CC HCV C Q&A V C C ALTGPT No
IFN IFN IFN IFN IFN n n IFN IFN IFN IFN IFN n IFN IFN n IFN IFN n n IFN IFN IFN IFN IFN IFN IFN IFN No
PhPhPh Ph PhPh Pharmaprojects BiologicalBI Pharmaprojects No
Reichert mrna DNA mrna mrna RNAisiRNA sirna RNAi/siRNA ReichertJanice Met al Nature Biotechnology Vitravene fomivirsennovartisisis ICAM Macugen pegaptanibpfizergilead sciencevegf No
Gene Network No No M&A HS No SP Innovation in the pharmaceutical industry after the US patent reforms in thesan empirical study Review System for NDA Approval in the USA and Japan and their Performance of Review No
Status of Climical Trials & Approval Review in Japan Deloitte httpwwwcocokaradajp knowhow erabi index html NEDO NEDO JPM IMS No
No No The Review of New Drug Applications in JapanThe Decline in Approval Times After the Introduction of an Internalized Review System Drug Information Journal Vol Nop No No
OPIR Office of Pharmaceutical Industry Research TEL FAX httpwwwjpmaorjpopir